title: Corrigendum.
abstract: This corrects the article: Steven G. Potkin, Tatsuya Kimura and John Guarino. A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia. Therapeutic Advances in Psychopharmacology 2045125315606027, first published on October 9, 2015. Doi:10.1177/2045125315606027.